AU5052899A - Genetic polymorphisms in the human neurokinin 1 receptor gene and their uses in diagnosis and treatment of diseases - Google Patents

Genetic polymorphisms in the human neurokinin 1 receptor gene and their uses in diagnosis and treatment of diseases

Info

Publication number
AU5052899A
AU5052899A AU50528/99A AU5052899A AU5052899A AU 5052899 A AU5052899 A AU 5052899A AU 50528/99 A AU50528/99 A AU 50528/99A AU 5052899 A AU5052899 A AU 5052899A AU 5052899 A AU5052899 A AU 5052899A
Authority
AU
Australia
Prior art keywords
diagnosis
diseases
treatment
receptor gene
genetic polymorphisms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU50528/99A
Other languages
English (en)
Inventor
Rakesh Anand
John Edward Norris Morten
John Craig Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9816192.0A external-priority patent/GB9816192D0/en
Priority claimed from GBGB9818280.1A external-priority patent/GB9818280D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of AU5052899A publication Critical patent/AU5052899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Neurology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU50528/99A 1998-07-25 1999-07-20 Genetic polymorphisms in the human neurokinin 1 receptor gene and their uses in diagnosis and treatment of diseases Abandoned AU5052899A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9816192 1998-07-25
GBGB9816192.0A GB9816192D0 (en) 1998-07-25 1998-07-25 Chemical compounds
GBGB9818280.1A GB9818280D0 (en) 1998-08-22 1998-08-22 Chemical compounds
GB9818280 1998-08-22
PCT/GB1999/002340 WO2000006768A1 (en) 1998-07-25 1999-07-20 Genetic polymorphisms in the human neurokinin 1 receptor gene and their uses in diagnosis and treatment of diseases

Publications (1)

Publication Number Publication Date
AU5052899A true AU5052899A (en) 2000-02-21

Family

ID=26314109

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50528/99A Abandoned AU5052899A (en) 1998-07-25 1999-07-20 Genetic polymorphisms in the human neurokinin 1 receptor gene and their uses in diagnosis and treatment of diseases

Country Status (4)

Country Link
EP (1) EP1100962A1 (ja)
JP (1) JP2002521062A (ja)
AU (1) AU5052899A (ja)
WO (1) WO2000006768A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030054381A1 (en) * 2001-05-25 2003-03-20 Pfizer Inc. Genetic polymorphisms in the human neurokinin 1 receptor gene and their uses in diagnosis and treatment of diseases
WO2008039941A2 (en) 2006-09-27 2008-04-03 The Government Of The Usa As Represented By The Secretary Of The Dpt. Of Health And Human Services Scgb3a2 as a growth factor and anti-apoptotic agent
KR20240095363A (ko) 2016-05-20 2024-06-25 세다르스-신나이 메디칼 센터 유전자에 기반한 염증성 장 질환의 진단
CN107142305A (zh) * 2017-04-25 2017-09-08 郑州大学第附属医院 基于高分辨熔解曲线技术的迟发性耳聋基因突变检测引物组及试剂盒和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992016547A1 (en) * 1991-03-15 1992-10-01 The Children's Medical Center Corporation Controlling nk-1 receptor-mediated responses and related diagnostics
DE69227940T2 (de) * 1991-04-25 1999-08-05 Merck & Co., Inc., Rahway, N.J. Menschlicher Neurokinin-1-Rezeptor

Also Published As

Publication number Publication date
WO2000006768A1 (en) 2000-02-10
JP2002521062A (ja) 2002-07-16
EP1100962A1 (en) 2001-05-23

Similar Documents

Publication Publication Date Title
GB9925804D0 (en) Biological materials and method useful in the diagnosis and treatment of diseases
HUP0103654A2 (hu) Szmilagenin és/vagy anzurogenin-D alkalmazása Alzheimer-kór kezelésére szolgáló gyógyszerkészítmény előállítására
AU2639695A (en) Novel uses of triplex forming oligonucleotides for the treatment of human diseases
AU4053699A (en) Novel human genes and gene expression products
AU4187499A (en) Human genes and gene expression products v
AP2001002102A0 (en) Pharmaceutical agents for the treatment of parkinson's disease and adhd and microadenomas
AU4803997A (en) Polymorphisms and new genes in the region of the human hemochromatosis gene
HUP0201997A3 (en) Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications
AU5550800A (en) Diagnosis and treatment of alzheimer's disease
AU5052899A (en) Genetic polymorphisms in the human neurokinin 1 receptor gene and their uses in diagnosis and treatment of diseases
AU6494798A (en) Genomic sequence of the human mu-opioid receptor gene and the variants, polymorphisms and mutations thereof
AU5052599A (en) Genetic polymorphisms in the human neurokinin 2 receptor gene and their use in diagnosis and treatment of diseases
AU1867297A (en) Gene-therapeutic nucleic acid construct, production of same and use of same in the treatment of heart disorders
AU6401696A (en) Early onset alzheimer's disease gene and gene products
AU6263999A (en) Human genes and gene expression products
AU5876899A (en) Polymorphisms in the human alpha4 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases
AU7402600A (en) New sequence variants of the human beta1-adrenoreceptor genes and use thereof
AU5876399A (en) Polymorphisms in the human beta1 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases
AU4841296A (en) Diagnosis of and compositions and methods for the treatment of disease
AU5875599A (en) Polymorphisms in the human vcam-1 gene, suitable for diagnosis and treatment of vcam-1 ligand mediated diseases
AU1040700A (en) The genetic determination of genes and its use for the prophylaxis and therapy of diseases
AU2003240253A1 (en) Polymorphisms in the human gene for htr3b and their use in diagnostic and therapeutic applications
AU2003244498A1 (en) Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
AUPQ223999A0 (en) Intracellular feedback controls in the diagnosis and treatment of human disease
AU7500800A (en) Human fmo3 gene mutations and polymorphisms, and uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase